Literature DB >> 27832497

Adhesion GPCRs in Tumorigenesis.

Gabriela Aust1, Dan Zhu2, Erwin G Van Meir2, Lei Xu3.   

Abstract

Alterations in the homeostasis of several adhesion GPCRs (aGPCRs) have been observed in cancer. The main cellular functions regulated by aGPCRs are cell adhesion, migration, polarity, and guidance, which are all highly relevant to tumor cell biology. Expression of aGPCRs can be induced, increased, decreased, or silenced in the tumor or in stromal cells of the tumor microenvironment, including fibroblasts and endothelial and/or immune cells. For example, ADGRE5 (CD97) and ADGRG1 (GPR56) show increased expression in many cancers, and initial functional studies suggest that both are relevant for tumor cell migration and invasion. aGPCRs can also impact the regulation of angiogenesis by releasing soluble fragments following the cleavage of their extracellular domain (ECD) at the conserved GPCR-proteolytic site (GPS) or other more distal cleavage sites as typical for the ADGRB (BAI) family. Interrogation of in silico cancer databases suggests alterations in other aGPCR members and provides the impetus for further exploration of their potential role in cancer. Integration of knowledge on the expression, regulation, and function of aGPCRs in tumorigenesis is currently spurring the first preclinical studies to examine the potential of aGPCR or the related pathways as therapeutic targets.

Entities:  

Keywords:  Metastasis; Tumor angiogenesis; Tumor cell migration; Tumor invasion; Tumor therapy

Mesh:

Substances:

Year:  2016        PMID: 27832497      PMCID: PMC5389670          DOI: 10.1007/978-3-319-41523-9_17

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  150 in total

1.  GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.

Authors:  Xiaolong Tang; Rongrong Jin; Guojun Qu; Xiu Wang; Zhenxi Li; Zengjin Yuan; Chen Zhao; Stefan Siwko; Tieliu Shi; Ping Wang; Jianru Xiao; Mingyao Liu; Jian Luo
Journal:  Cancer Res       Date:  2013-09-05       Impact factor: 12.701

2.  Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model.

Authors:  A Mori; S Arii; M Furutani; K Hanaki; Y Takeda; T Moriga; Y Kondo; M J Gorrin Rivas; M Imamura
Journal:  Int J Cancer       Date:  1999-03-01       Impact factor: 7.396

3.  Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.

Authors:  Balveen Kaur; Sarah M Cork; Eric M Sandberg; Narra S Devi; Zhaobin Zhang; Philip A Klenotic; Maria Febbraio; Hyunsuk Shim; Hui Mao; Carol Tucker-Burden; Roy L Silverstein; Daniel J Brat; Jeffrey J Olson; Erwin G Van Meir
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

4.  Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas.

Authors:  Justyna Leja; Ahmed Essaghir; Magnus Essand; Kenneth Wester; Kjell Oberg; Thomas H Tötterman; Ricardo Lloyd; George Vasmatzis; Jean-Baptiste Demoulin; Valeria Giandomenico
Journal:  Mod Pathol       Date:  2008-10-24       Impact factor: 7.842

5.  Disease-associated mutations prevent GPR56-collagen III interaction.

Authors:  Rong Luo; Zhaohui Jin; Yiyu Deng; Natalie Strokes; Xianhua Piao
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

6.  The invasion and metastasis promotion role of CD97 small isoform in gastric carcinoma.

Authors:  Daren Liu; Bogusz Trojanowicz; Longyun Ye; Chao Li; Luqing Zhang; Xiaowen Li; Guogang Li; Yixiong Zheng; Li Chen
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

7.  G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.

Authors:  Kelsey L Whittier; Erin A Boese; Katherine N Gibson-Corley; Patricia A Kirby; Benjamin W Darbro; Qining Qian; Wendy J Ingram; Thomas Robertson; Marc Remke; Michael D Taylor; M Sue O'Dorisio
Journal:  Acta Neuropathol Commun       Date:  2013-10-10       Impact factor: 7.801

8.  Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer.

Authors:  Zheng He; Hui Wu; Yanli Jiao; Jun Zheng
Journal:  Oncol Lett       Date:  2014-12-01       Impact factor: 2.967

9.  SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis.

Authors:  Raul Aguirre-Gamboa; Hugo Gomez-Rueda; Emmanuel Martínez-Ledesma; Antonio Martínez-Torteya; Rafael Chacolla-Huaringa; Alberto Rodriguez-Barrientos; José G Tamez-Peña; Victor Treviño
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

10.  Skeletal muscle expression of the adhesion-GPCR CD97: CD97 deletion induces an abnormal structure of the sarcoplasmatic reticulum but does not impair skeletal muscle function.

Authors:  Tatiana Zyryanova; Rick Schneider; Volker Adams; Doreen Sittig; Christiane Kerner; Claudia Gebhardt; Henrik Ruffert; Stefan Glasmacher; Pierre Hepp; Karla Punkt; Jochen Neuhaus; Jörg Hamann; Gabriela Aust
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

View more
  30 in total

Review 1.  The Emerging Role of Adhesion GPCRs in Cancer.

Authors:  Abanoub A Gad; Nariman Balenga
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-13

Review 2.  GPCRomics: An Approach to Discover GPCR Drug Targets.

Authors:  Paul A Insel; Krishna Sriram; Matthew W Gorr; Shu Z Wiley; Alexander Michkov; Cristina Salmerón; Amy M Chinn
Journal:  Trends Pharmacol Sci       Date:  2019-05-08       Impact factor: 14.819

3.  Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Authors:  Juan-Jose Garcés; Michal Simicek; Marco Vicari; Lucie Brozova; Leire Burgos; Renata Bezdekova; Diego Alignani; Maria-Jose Calasanz; Katerina Growkova; Ibai Goicoechea; Xabier Agirre; Ludek Pour; Felipe Prosper; Rafael Rios; Joaquin Martinez-Lopez; Pamela Millacoy; Luis Palomera; Rafael Del Orbe; Albert Perez-Montaña; Sonia Garate; Laura Blanco; Marta Lasa; Patricia Maiso; Juan Flores-Montero; Luzalba Sanoja-Flores; Zuzana Chyra; Alexander Vdovin; Tereza Sevcikova; Tomas Jelinek; Cirino Botta; Halima El Omri; Jonathan Keats; Alberto Orfao; Roman Hajek; Jesus F San-Miguel; Bruno Paiva
Journal:  Leukemia       Date:  2019-10-08       Impact factor: 11.528

Review 4.  Adhesion G protein-coupled receptor gluing action guides tissue development and disease.

Authors:  Abhijit Sreepada; Mansi Tiwari; Kasturi Pal
Journal:  J Mol Med (Berl)       Date:  2022-08-15       Impact factor: 5.606

5.  Spatial regulation of GPR64/ADGRG2 signaling by β-arrestins and GPCR kinases.

Authors:  Pedram Azimzadeh; Sarah C Talamantez-Lyburn; Katarina T Chang; Asuka Inoue; Nariman Balenga
Journal:  Ann N Y Acad Sci       Date:  2019-09-09       Impact factor: 5.691

Review 6.  Adhesion G Protein-Coupled Receptors as Drug Targets.

Authors:  Ryan H Purcell; Randy A Hall
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-02       Impact factor: 13.820

7.  Gedunin- and Khivorin-Derivatives Are Small-Molecule Partial Agonists for Adhesion G Protein-Coupled Receptors GPR56/ADGRG1 and GPR114/ADGRG5.

Authors:  Hannah M Stoveken; Scott D Larsen; Alan V Smrcka; Gregory G Tall
Journal:  Mol Pharmacol       Date:  2018-02-23       Impact factor: 4.436

Review 8.  G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers.

Authors:  Nadia Arang; J Silvio Gutkind
Journal:  FEBS Lett       Date:  2020-12       Impact factor: 4.124

Review 9.  ELTD1-An Emerging Silent Actor in Cancer Drama Play.

Authors:  Ani-Simona Sevastre; Iuliana M Buzatu; Carina Baloi; Alexandru Oprita; Alexandra Dragoi; Ligia G Tataranu; Oana Alexandru; Stefania Tudorache; Anica Dricu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

10.  A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer.

Authors:  Noor Mazin Abdulkareem; Raksha Bhat; Lanfang Qin; Suhas Vasaikar; Ambily Gopinathan; Tamika Mitchell; Martin J Shea; Sarmistha Nanda; Hariprasad Thangavel; Bing Zhang; Carmine De Angelis; Rachel Schiff; Meghana V Trivedi
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.